Who We are and what we do
Founded in 1997 and owned by Al Ritaj Holding, Pharo Pharma stands as a distinguished leader in pharmaceutical manufacturing and marketing across the MENA region. With a diverse portfolio of over 270 pharmaceutical brands produced at our world-class facility in Borg El-Arab, Alexandria, we are redefining industry standards in quality and innovation.
Ranked among Egypt’s top 30 pharmaceutical companies, Pharo Pharma is on a steadfast journey to becoming one of the top 10 through a forward-thinking approach, exceptional operational systems, and a culture of excellence.
Our products, recognized for their superior quality, are exported to over 14 countries, reflecting our commitment to improving healthcare on a global scale.
With a production capacity exceeding 50 million units annually, we are dedicated to serving patients with high-quality products and services. Over the past year, we launched a groundbreaking sterile production area, boosting our capacity and setting a new benchmark for quality in the region. Additionally, the establishment of two new strategic promotional units has strengthened our ability to deliver value and support the launch of innovative pharmaceutical solutions.
At Pharo Pharma, we are not just meeting the needs of today’s healthcare landscape, we are shaping the future of pharmaceutical innovation with unwavering dedication to progress and excellence.
OUR History
Factory Establishment
First production to the local market
First natural based products in market (Guava)
New production line for Blistering,
PAM Filling, Automatic Inspection & Labeling Machines.
Export to Africa (Sudan – Yamin)
Number 1 in market
for products (Digenorm – OMEZ)
Acquired by Al-Ritaj Group
Sterile Production line
for Ampoules and drops
Toll in for other pharma companies
Production volume 100 million unit
Updating Coating Machine
Establishing new warehouse
Exporting to more than 14 countries
focusing on Africa & Middle-east
Our Mission
To establish ourselves as a leader in the generic pharmaceutical market by providing superior quality products and outstanding services to the healthcare community. We are committed to being a trusted business partner to all stakeholders patients, customers, investors, distributors, suppliers and employees by fostering integrity, synergy and mutual trust to achieve shared success.
Our Vision
PHARAONIA PHARMACEUTICALS aspires to be one of the top pharmaceutical leaders in Egypt, targeting a place among the top ten generic manufacturers in the region, driven by our unwavering commitment to quality and our passion for enhancing health and wellness.
Our Core Values
Integrity
Respect
Equality
Agility
Solidarity – Collaboration
Results
Consumer Loyalty
Board of directors
Chairman
Mr. Meshal Abdullah Aljassar
Vice Chairman
Dr. Abdullah Monged Badr
BOD Member
Dr. Mohamed Faisal Alqenai
BOD Member
Mr. Ali Attalah Al-Mutairi
BOD Member
Dr. Nasser Metwaly Alnomrosy
Group Chief Executive Officer
Dr. Salah Adelsadek Mousa
executive leadership team
Our experienced leadership team keeps us on track
Group Chief Technical Affairs Officer
Dr. Ahmed Ezz El Din
Group Marketing & Business Development Senior Director
Dr. Khalid Ibrahim
Group Chief Commercial Officer
Dr. Ahmed Azouz
Group Regulatory Affairs Officer
Dr. Iman Fada
Medical & Pharmacovigilance Director
Dr. Alaa Eldin Abo Elyazid
Supply Chain Manager
Eng. Rehab Refaat
Legal Affairs Director
Mr. Youssef El-Moslemany
Finance Director
Mr. Ayman Salah
Group Information Technology Director
Mr. Mohamed Mostafa
Group Internal Audit Director
Mr. Islam Samir
Group Compliance and Risk Management Director
Mr. Mohamed Haassan
Group Head of Human Resources and Administration
Mr. Mohamed Nasr
Certification and Authorizations
ISO 9001 :2015
This certificate is valid from 22 December 2021 until 15 December 2024 and remains valid subject to satisfactory surveillance audits. Recertification audit due a minimum of 60 days before the expiration date. Issue 4. Certified since 15 December 2015
ISO 14001 :2015
This certificate is valid from 22 December 2021 until 15 December 2024 and remains valid subject to satisfactory surveillance audits. Recertification audit due a minimum of 60 days before the expiration date. issue 4. Certified since 15 December 2015
ISO 45001 :2018
This certificate is valid from 22 December 2021 until 13 December 2024 and remains valid subject to satisfactory surveillance audits. Recef!ification audit due a minimum of 60 days before the expiration date. Issue 3. Certified since 26 February 2021